Drug Safety

A Risk Worth Taking?
pp. 801-804(4)
Author: Edwards, I. Ralph

Public Perceptions of the Pharmaceutical Industry and Drug Safety: Implications for the Pharmacovigilance Professional and the Culture of Safety
pp. 805-810(6)
Authors: Olsen, Axel K.; Whalen, Matthew D.

Pharmacovigilance of Biopharmaceuticals: Challenges Remain
pp. 811-817(7)
Authors: Giezen, Thijs J.; Mantel-Teeuwisse, Aukje K.; Leufkens, Hubert G.M.

The Causes of and Factors Associated with Prescribing Errors in Hospital Inpatients: A Systematic Review
pp. 819-836(18)
Authors: Tully, Mary P.; Ashcroft, Darren M.; Dornan, Tim; Lewis, Penny J.; Taylor, David; Wass, Val

Communicating the Risk of Side Effects to Patients: An Evaluation of UK Regulatory Recommendations
pp. 837-849(13)
Authors: Knapp, Peter; Raynor, David K.; Woolf, Elizabeth; Gardner, Peter H.; Carrigan, Neil; McMillan, Brian

Reporting of Adverse Drug Reactions by General Practitioners: A Questionnaire-Based Study in the Netherlands
pp. 851-858(8)
Authors: Passier, Anneke; >Marije ten Napel,; >Kees van Grootheest,; >Eugène van Puijenbroek,

Evaluation of Abuse and Dependence on Drugs Used for Self-Medication: A Pharmacoepidemiological Pilot Study Based on Community Pharmacies in France
pp. 859-873(15)
Authors: Orriols, Ludivine; Gaillard, Julia; Lapeyre-Mestre, Maryse; Roussin, Anne

ABSTRACTS: 9th ISoP Annual Meeting `From Pharmacovigilance to Risk Management', Reims, France, 6-9 October 2009
pp. 875-993(119)